Gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproductive treatment

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Maheshwari, Abha ^a   Bhattacharya, S ^b   Daya, S ^b   Gibreel, A ^b   Siristatidis, C S ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST;

CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FERTILIZATION IN VITRO; HUMAN; HYPOPHYSIS; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; OVULATION INDUCTION; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW;

EID: 44949162089     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006919     Document Type: Review

References (16)

1. Belchetz 1978 Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. Hypophyseal responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science 1978;202:631-3.
2. Dal Prato 2004 Dal Prato L, Borini A, Coticchio G, Cattoli M, Flamigni C. Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study. Human Reproduction 2004;19(10):2200-5.
3. Deeks 2005 Deeks JJ, Higgins JPT, Altman DG, editors. Analysing and presenting results. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005].
4. Dirnfeld 1999 Dirnfeld M, Fruchter O, Yshai D, Lissak A, Ahdut A, Abramovici H. Cessation of gonadotrophin-releasing hormone analogue (GnRHa) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization. Fertility and Sterility 1999;72(3):406-11.
5. Donderwinkel 1993 Donderwinkel PF, Schoot DC, Pache TD, de Jong FH, Hop WC, Fauser BC. Luteal function following ovulation induction in polycystic ovary syndrome patients using exogeneous gonadotrophins in combination with a gonadotrophn-releasing hormone agonist. Human Reproduction 1993;8:2027-32.
6. Faber 1998 Faber BM, Mayer J, Cox B, Jones D, Toner JP, Oehninger S, et al.Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favourable pregnancy results in low responders. Fertility and Sterility 1998;69:826-830.
7. Fujii 1997 Fujii S, Sagara M, Kudo H, Kagiya A, Sato S, Saito Y. A prospective randomized comparison between long and discontinous-long protocols of gonadotropin-releasing hormone agonist for in vitro fertilization. Fertility and Sterility 1997;67(6):1166-1168.
8. Homburg 1988 Homburg R, Arman NA, Eshel A, Adams J, Jacobs HS. Influence of serumluteinizing hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988;297:1024-6.
9. Howles 1987 Howles C, Macnamee MC, Edwards RG. Follicular development and early luteal function of conception and non-conceptional cycles after human in vitro fertilization: endocrine correlates. Human Reproduction 1987;2:17-21.
10. Hughes 1992 Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de Koppel P, Collins JA. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized trials. Fertility and Sterility 1992;58:888-96.
11. Knobil 1980 Knobil E. The neuroendocrine control of the menstrual cycle. Recent Progress in Hormone Research 1980;36:53-81.
12. Regan 1990 Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinizing hormone, infertility and miscarriage. Lancet 1990;336:1141-4.
13. Simons 2005 Simons AHM, Roelofs HJM, Schmoutziguer APE, Roozenburg BJ, vant Hof-van den Brink EP, Schoonderwoerd SA. Early cessation of triptorelin in in vitro fertilization: a double blinded, randomized study. Fertility and Sterility 2005;83(4):889-96.
14. Smitz 1992 Smitz J, Erard P, Camus M, Devroey P, Tournaye H, Wisanto A, et al.Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. Human Reproduction 1992;7:1225-9.
15. Stanger 1985 Stanger J, Yovich JJ. Reduced in vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. British Journal of Obstetrics and Gynaecology 1985;92:385-93.
16. Westergaard 2000 Westergaard LG, Laursen SB, Anderson CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Human Reproduction 2000;15:1003-8.